Stay updated on Pembrolizumab for Lung Cancer Prevention Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.

Latest updates to the Pembrolizumab for Lung Cancer Prevention Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision label changes from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding notice banner at the top of the page was removed. There are no changes to the study details or other content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedThe core study information and sections (Overview, Eligibility Criteria, Study Plan, and Outcomes) remain unchanged across the screenshots; only formatting differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedImportant updates include a notice about government funding impacts and operating status, plus a new version (v3.2.0); the old version tag (v3.1.0) was removed. If no other major content changes are present, this represents an operational update rather than a broad content overhaul.SummaryDifference2%

- Check78 days agoChange DetectedUpdated the page to reflect a new software version (from v3.0.2 to v3.1.0).SummaryDifference0.1%

- Check92 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2, indicating a newer revision. The 'Back to Top' element was removed, representing a minor UI change.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Lung Cancer Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.